Recovery act tissue samples and data from various types of cancer for the cancer genome atlas (tcga) program arra::yes::arra
Ended Awarded Last action
- Contract number
- HHSN26100001
- Awardee
-
Brigham & Womens Hospital Inc. UEI QN6MS4VN7BD1 Part of Partners Healthcare System Incorporated
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $143,588
Award facts
- Contract value 100% obligated
- $143,587.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Boston, MA 02115, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$112,350 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $177,188 | |
| Original award | $78,750 |
About this award
This is a firm fixed price delivery order contract awarded by the National Cancer Institute (NCI), part of the Department of Health and Human Services, to Brigham & Women's Hospital, Inc. The $143,587.50 contract supports the Cancer Genome Atlas (TCGA) program's effort to collect tissue samples and data from various types of cancer. The award is funded through the American Recovery and Reinvestment Act (ARRA) and does not have a small business set-aside designation. Brigham & Women's Hospital, a subsidiary of the larger Partners Healthcare System Incorporated, has a long history of receiving federal research contracts and grants from agencies like the National Institutes of Health, Department of Veterans Affairs, and Department of Defense to advance medical knowledge across specialties like oncology, neurology, and cardiovascular health. This specific delivery order contract is issued under the NCI's Cancer Genome Atlas Program Tissue Purchase indefinite delivery vehicle.
Quick answers
Who was awarded contract HHSN26100001?
HHSN26100001 was awarded to Brigham & Womens Hospital Inc. by National Cancer Institute (National Institutes of Health) on June 23, 2010.
How much is contract HHSN26100001 worth?
The government has obligated $143,588 on HHSN26100001.
Is contract HHSN26100001 an order under another contract?
Yes. HHSN26100001 is a delivery order under HHSN261201000051I, an indefinite delivery contract, on NCI Cancer Genome Atlas Program Tissue Purchase.
Was contract HHSN26100001 competed?
The extent of competition for HHSN26100001 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award